These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors. Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues. Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947 [TBL] [Abstract][Full Text] [Related]
4. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands. Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118 [TBL] [Abstract][Full Text] [Related]
5. Anxiolytic-like effect of a selective and non-peptidergic melanocortin 4 receptor antagonist, MCL0129, in a social interaction test. Shimazaki T; Chaki S Pharmacol Biochem Behav; 2005 Mar; 80(3):395-400. PubMed ID: 15740781 [TBL] [Abstract][Full Text] [Related]
6. Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119. Schiöth HB; Muceniece R; Mutulis F; Bouifrouri AA; Mutule I; Wikberg JE Neuropeptides; 1999 Jun; 33(3):191-6. PubMed ID: 10657491 [TBL] [Abstract][Full Text] [Related]
7. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432 [TBL] [Abstract][Full Text] [Related]
8. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach. Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337 [TBL] [Abstract][Full Text] [Related]
9. Potent and selective agonists of human melanocortin receptor 5: cyclic analogues of alpha-melanocyte-stimulating hormone. Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A J Med Chem; 2007 May; 50(10):2520-6. PubMed ID: 17455928 [TBL] [Abstract][Full Text] [Related]
10. Design of novel chimeric melanotropin-deltorphin analogues. Discovery of the first potent human melanocortin 1 receptor antagonist. Han G; Quillan JM; Carlson K; Sadée W; Hruby VJ J Med Chem; 2003 Feb; 46(5):810-9. PubMed ID: 12593660 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template. Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of a novel potent cyclic peptide MC4-ligand by ring-closing metathesis. Wels B; Kruijtzer JA; Garner K; Nijenhuis WA; Gispen WH; Adan RA; Liskamp RM Bioorg Med Chem; 2005 Jul; 13(13):4221-7. PubMed ID: 15876540 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and activity of the melanocortin Xaa-d-Phe-Arg-Trp-NH tetrapeptides with amide bond modifications. Todorovic A; Holder JR; Scott JW; Haskell-Luevano C J Pept Res; 2004 Mar; 63(3):270-8. PubMed ID: 15049839 [TBL] [Abstract][Full Text] [Related]
15. Potent and selective agonists of alpha-melanotropin (alphaMSH) action at human melanocortin receptor 5; linear analogs of alpha-melanotropin. Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A Peptides; 2007 May; 28(5):1020-8. PubMed ID: 17376561 [TBL] [Abstract][Full Text] [Related]
16. Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphisms. Xiang Z; Pogozheva ID; Sorenson NB; Wilczynski AM; Holder JR; Litherland SA; Millard WJ; Mosberg HI; Haskell-Luevano C Biochemistry; 2007 Jul; 46(28):8273-87. PubMed ID: 17590021 [TBL] [Abstract][Full Text] [Related]
17. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat. Adan RA; Szklarczyk AW; Oosterom J; Brakkee JH; Nijenhuis WA; Schaaper WM; Meloen RH; Gispen WH Eur J Pharmacol; 1999 Aug; 378(3):249-58. PubMed ID: 10493100 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R. Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6. Grieco P; Han G; Weinberg D; Van der Ploeg LH; Hruby VJ Biochem Biophys Res Commun; 2002 Apr; 292(4):1075-80. PubMed ID: 11944925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]